Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Path Holdings (BPTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,333
  • Shares Outstanding, K 2,507
  • Annual Sales, $ 40 K
  • Annual Income, $ -7,020 K
  • 60-Month Beta 2.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.84 +1,094.57%
on 02/27/19
73.52 -70.10%
on 03/07/19
+19.78 (+899.09%)
since 02/22/19
3-Month
1.61 +1,265.22%
on 01/22/19
73.52 -70.10%
on 03/07/19
+17.38 (+377.83%)
since 12/21/18
52-Week
1.61 +1,265.22%
on 01/22/19
73.52 -70.10%
on 03/07/19
-13.42 (-37.91%)
since 03/22/18

Most Recent Stories

More News
Bio-Path Holdings Reports Full Year 2018 Financial Results

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 21.98 (+18.94%)
Bio-Path Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 20, 2019 / Bio-Path Holdings, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 20, 2019 at 8:30 AM Eastern...

BPTH : 21.98 (+18.94%)
Estimated Revenues Continue to Rise for U.S. and Global Medical Device Markets

The U.S. medical device industry has seen its revenues continue to increase and it is poised is to become the global leader of this expanding market. It seems as though each new projection breaks through...

DERM : 12.99 (-4.63%)
ATOS : 3.68 (-1.34%)
BPTH : 21.98 (+18.94%)
AVGR : 0.88 (-4.36%)
SOLY : 7.82 (-1.67%)
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 21.98 (+18.94%)
Bio-Path Holdings, Inc. Announces Closing of $18.5 Million Registered Direct Offering of Common Stock

Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize(R) antisense RNAi nanoparticle technology to develop a portfolio of targeted...

BPTH : 21.98 (+18.94%)
Bio-Path Holdings, Inc. Announces $18.5 Million Registered Direct Offering of Common Stock

Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize(R) antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid...

BPTH : 21.98 (+18.94%)
FDA Regulations Allow Medical Devices Clinical Trials to Differ From Pharmaceutical Trials

Clinical trials are the pathway for new drugs or devices to enter the U.S. and other worldwide markets. However, not all clinical trials are the same. A recent article by a 20+ year insider in the clinical...

ARQL : 4.82 (-6.23%)
LLY : 128.30 (-0.01%)
BPTH : 21.98 (+18.94%)
SOLY : 7.82 (-1.67%)
SEEL : 2.59 (+15.11%)
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

Interim Data Update from Phase 2 Study Demonstrates Meaningful Clinical Improvement with Excellent Patient Safety Profile

BPTH : 21.98 (+18.94%)
Thinking about buying stock in AmBev, Advanced Micro Devices, Bio-Path Holdings, The Gap or Weatherford International?

InvestorsObserver issues critical PriceWatch Alerts for ABEV, AMD, BPTH, GPS, and WFT.

WFT : 0.75 (-4.93%)
AMD : 26.37 (-5.45%)
GPS : 24.52 (-2.39%)
ABEV : 4.28 (-4.04%)
BPTH : 21.98 (+18.94%)
U.S. Medical Device Market Reaches $156 Billion Mark

Medical technology is an area where the U.S. companies are at the forefront. In fact, according to recent industry publication the: "U.S. remains the largest medical device market in the world, with a...

TGTX : 6.83 (-7.58%)
AMRN : 17.51 (-6.66%)
PBYI : 39.03 (-3.37%)
BPTH : 21.98 (+18.94%)
SOLY : 7.82 (-1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BPTH with:

Business Summary

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout...

See More

Key Turning Points

2nd Resistance Point 26.39
1st Resistance Point 24.19
Last Price 21.98
1st Support Level 20.49
2nd Support Level 18.99

See More

52-Week High 73.52
Fibonacci 61.8% 46.05
Fibonacci 50% 37.56
Fibonacci 38.2% 29.08
Last Price 21.98
52-Week Low 1.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar